This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
In a new approach to developing treatments for breast cancer, prostate cancer and enlarged hearts, Loyola University Chicago Stritch School of Medicine researchers are zeroing in on a workhorse protein called RSK.
We care about your feedback. Let us know how we can improve your CancerCompass experience.